Are preoperative inflammatory and nutritional markers important for the prognosis of patients with peritoneal metastasis of colorectal cancer?

doi:10.4251/wjgo.v16.i11.4522

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (789)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

HTML

396

Tables (1-2)

Sum=503

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=150

Publishing Process of This Article

Item

Count

Browse

Download

Sum=101

Nov 15, 2024 (publication date) through Jan 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastrointest Oncol. Nov 15, 2024; 16(11): 4522-4527
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4522

Are preoperative inflammatory and nutritional markers important for the prognosis of patients with peritoneal metastasis of colorectal cancer?

Isabella Sforzin, Mitesh Borad, Pedro Luiz Serrano Uson Junior

Isabella Sforzin, Pedro Luiz Serrano Uson Junior, Center for Personalized Medicine, Hospital Israelita Albert Einstein, São Paulo 05652900, Brazil

Mitesh Borad, Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Arizona, Mayo Clinic Cancer Center, Phoenix, AZ 85054, United States

Author contributions: Uson Junior PLS, Borad M, and Sforzin I contributed to the development of this paper, including the writing, editing of the manuscript, preparation of tables, and review of the literature.

Conflict-of-interest statement: The authors declare no conflicts of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Pedro Luiz Serrano Uson Junior, MD, Academic Editor, Academic Research, Assistant Professor, Teacher, Center for Personalized Medicine, Hospital Israelita Albert Einstein, Avenida Albert Einstein 627, São Paulo 05652900, Brazil. pedro.serrano@einstein.br

Received: August 1, 2024
Revised: September 14, 2024
Accepted: September 24, 2024
Published online: November 15, 2024
Processing time: 84 Days and 14.5 Hours

Core Tip

Core Tip: In this study, the clinical data of patients with colorectal cancer (CRC) from a single center were retrospectively analyzed. A high neutrophil-to-lymphocyte ratio and low hemoglobin levels were independent predictive risk factors for poor prognosis in patients with peritoneal metastasis (PM) of CRC. The established nomogram including CA 19-9 levels and patient age accurately predicted the overall survival of patients having PM, indicating its usefulness as a valuable prognostic tool for this patient cohort.